55:
182:
Cessation of steroid therapy or treatment of the cause of
Cushing's syndrome causes moon face to slowly decrease and eventually vanish. One study proposed that limiting calories could decrease the risk of corticosteroid-induced lipodystrophy.
154:
This change in facial appearance can be very distressing to patients taking steroids. Later studies of the 88 patients showed that those who had lipodystrophy had a greater risk for
130:
Another long-term study of 88 patients on prednisone showed that lipodystrophy, such as moon face, was the most frequent adverse event, experienced by 63% of patients.
699:"[Systemic corticosteroid therapy: patients' adherence to dietary advice and relationship between food intake and corticosteroid-induced lipodystrophy]"
111:
along with "buffalo hump", which in one study occurred in 47% of the 820 patients. Moon face is among the most frequently reported adverse events of systemic
442:"Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients"
601:"The man-in-the-moon face: a qualitative study of body image, self-image and medication use in systemic lupus erythematosus"
108:
142:
treatment. One study showed an increased risk in women, those younger than 50 years of age, and those with a high initial
342:
418:
282:
495:
Fardet, L.; Flahault, A.; Kettaneh, A.; Tiev, K. P.; Généreau, T.; Tolédano, C.; Lebbé, C.; Cabane, J. (July 2007).
17:
697:
Fardet, L.; Flahault, A.; Kettaneh, A.; Tiev, K.-P.; Tolédano, C.; Lebbe, C.; Cabane, J. (May 2007).
28:
360:"Cushing's disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment"
171:
552:
Fardet, Laurence; Cabane, Jean; Lebbé, Céleste; Morel, Patrice; Flahault, Antoine (October 2007).
334:
813:
497:"Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion"
791:
89:
650:"Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome"
326:
554:"Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study"
8:
534:
477:
384:
359:
248:
221:
199:
155:
358:
Buliman, A.; Tataranu, L. G.; Paun, D. L.; Mirica, A.; Dumitrache, C. (January 2016).
762:
726:
718:
679:
671:
630:
622:
581:
573:
526:
518:
513:
496:
469:
461:
414:
389:
371:
338:
327:
278:
253:
538:
481:
710:
661:
612:
565:
508:
453:
379:
243:
233:
666:
649:
617:
600:
714:
408:
406:
304:
272:
143:
139:
97:
77:
767:
569:
159:
112:
457:
222:"Iatrogenic Cushing's syndrome with inhaled steroid plus antidepressant drugs"
807:
722:
675:
626:
577:
522:
465:
375:
120:
698:
553:
441:
730:
683:
648:
Fardet, L.; Cabane, J.; Kettaneh, A.; Lebbé, C.; Flahault, A. (July 2007).
634:
585:
530:
473:
393:
257:
238:
163:
73:
786:
167:
599:
Hale, Elizabeth D.; Radvanski, Diane C.; Hassett, Afton L. (July 2015).
277:. Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 364.
124:
754:
138:
The risk for moon face increases with higher doses and longer time on
76:
in which the face develops a rounded appearance (reminiscent of the "
116:
93:
407:
Bricker, S.L.; B C Decker; Langlais, R.P.; Miller, C.S. (2001).
220:
Celik, O; Niyazoglu, M; Soylu, H; Kadioglu, P (29 August 2012).
54:
333:(24th ed.). Philadelphia: Elsevier Saunders. pp.
219:
696:
494:
647:
357:
274:
Nurse's Five-minute
Clinical Consult: Signs and symptoms
551:
410:
Oral
Diagnosis, Oral Medicine, and Treatment Planning
744:
598:
48:
Moon facies, Cushingoid facies, Cushing's-like face
440:Morin, Clément; Fardet, Laurence (December 2015).
213:
80:") due to fat deposits on the sides of the face.
805:
558:Journal of the American Academy of Dermatology
270:
439:
62:Moon face resulting from steroid treatment.
53:
665:
616:
512:
383:
247:
237:
324:
14:
806:
400:
226:Multidisciplinary Respiratory Medicine
100:), which has led to it being known as
83:
264:
318:
297:
109:corticosteroid-induced lipodystrophy
305:"Moon Facies: Causes and Treatment"
88:Moon face is often associated with
24:
501:The British Journal of Dermatology
162:, higher plasma concentrations of
158:characteristics such as increased
25:
825:
740:
514:10.1111/j.1365-2133.2007.07950.x
202:. Biology-Online.org. 2009-09-07
149:
690:
641:
592:
545:
200:"Moon facies - definition from"
488:
433:
351:
192:
13:
1:
186:
715:10.1016/j.revmed.2006.12.013
703:La Revue de MĂ©decine Interne
413:. B.C. Decker. p. 540.
364:Journal of Medicine and Life
177:
133:
7:
667:10.1093/rheumatology/kem062
618:10.1093/rheumatology/keu448
10:
830:
570:10.1016/j.jaad.2007.04.018
26:
777:
748:
458:10.1007/s10067-015-2953-7
61:
52:
44:
39:
29:Moonface (disambiguation)
329:Goldman's Cecil Medicine
123:disturbances (50%), and
107:Moon face is a type of
271:Wilkins, L.W. (2008).
239:10.1186/2049-6958-7-26
96:treatment (especially
446:Clinical Rheumatology
325:Goldman, Lee (2011).
166:, triglycerides, and
27:For other uses, see
170:, along with lower
84:Symptoms and causes
778:External resources
156:metabolic syndrome
90:Cushing's syndrome
801:
800:
452:(12): 2119–2126.
168:total cholesterol
102:Cushingoid facies
66:
65:
34:Medical condition
16:(Redirected from
821:
746:
745:
735:
734:
694:
688:
687:
669:
660:(7): 1102–1106.
645:
639:
638:
620:
611:(7): 1220–1225.
596:
590:
589:
549:
543:
542:
516:
492:
486:
485:
437:
431:
430:
428:
427:
404:
398:
397:
387:
355:
349:
348:
332:
322:
316:
315:
313:
312:
301:
295:
294:
292:
291:
268:
262:
261:
251:
241:
217:
211:
210:
208:
207:
196:
57:
37:
36:
21:
829:
828:
824:
823:
822:
820:
819:
818:
804:
803:
802:
797:
796:
773:
772:
757:
743:
738:
695:
691:
646:
642:
597:
593:
550:
546:
493:
489:
438:
434:
425:
423:
421:
405:
401:
356:
352:
345:
323:
319:
310:
308:
303:
302:
298:
289:
287:
285:
269:
265:
218:
214:
205:
203:
198:
197:
193:
189:
180:
164:fasting glucose
152:
136:
113:glucocorticoids
98:corticosteroids
86:
78:Man in the Moon
35:
32:
23:
22:
15:
12:
11:
5:
827:
817:
816:
799:
798:
795:
794:
782:
781:
779:
775:
774:
771:
770:
758:
753:
752:
750:
749:Classification
742:
741:External links
739:
737:
736:
709:(5): 284–288.
689:
640:
591:
564:(4): 604–609.
544:
507:(1): 142–148.
487:
432:
419:
399:
350:
344:978-1437727883
343:
317:
296:
283:
263:
212:
190:
188:
185:
179:
176:
174:-cholesterol.
160:blood pressure
151:
148:
135:
132:
85:
82:
64:
63:
59:
58:
50:
49:
46:
42:
41:
33:
9:
6:
4:
3:
2:
826:
815:
814:Medical signs
812:
811:
809:
793:
789:
788:
784:
783:
780:
776:
769:
765:
764:
760:
759:
756:
751:
747:
732:
728:
724:
720:
716:
712:
708:
704:
700:
693:
685:
681:
677:
673:
668:
663:
659:
655:
651:
644:
636:
632:
628:
624:
619:
614:
610:
606:
602:
595:
587:
583:
579:
575:
571:
567:
563:
559:
555:
548:
540:
536:
532:
528:
524:
520:
515:
510:
506:
502:
498:
491:
483:
479:
475:
471:
467:
463:
459:
455:
451:
447:
443:
436:
422:
420:9781550092066
416:
412:
411:
403:
395:
391:
386:
381:
377:
373:
369:
365:
361:
354:
346:
340:
336:
331:
330:
321:
306:
300:
286:
284:9781582557038
280:
276:
275:
267:
259:
255:
250:
245:
240:
235:
231:
227:
223:
216:
201:
195:
191:
184:
175:
173:
169:
165:
161:
157:
150:Complications
147:
145:
141:
131:
128:
126:
122:
118:
115:, along with
114:
110:
105:
103:
99:
95:
91:
81:
79:
75:
71:
60:
56:
51:
47:
43:
38:
30:
19:
785:
761:
706:
702:
692:
657:
654:Rheumatology
653:
643:
608:
605:Rheumatology
604:
594:
561:
557:
547:
504:
500:
490:
449:
445:
435:
424:. Retrieved
409:
402:
370:(1): 12–18.
367:
363:
353:
328:
320:
309:. Retrieved
299:
288:. Retrieved
273:
266:
229:
225:
215:
204:. Retrieved
194:
181:
153:
137:
129:
106:
101:
87:
74:medical sign
69:
67:
787:MedlinePlus
307:. webmd.com
125:hyperphagia
45:Other names
18:Moon facies
763:DiseasesDB
426:2015-06-12
311:2015-06-12
290:2015-06-12
206:2013-05-22
187:References
723:0248-8663
676:1462-0324
627:1462-0332
578:1097-6787
523:0007-0963
466:1434-9949
376:1844-3117
232:(1): 26.
178:Treatment
134:Incidence
70:Moon face
40:Moon face
808:Category
731:17391811
684:17409127
635:25550393
586:17582650
539:31057174
531:17501951
482:21395473
474:25956956
394:27974908
258:22958272
117:insomnia
385:5152600
249:3436715
140:steroid
127:(49%).
119:(58%),
94:steroid
792:003105
729:
721:
682:
674:
633:
625:
584:
576:
537:
529:
521:
480:
472:
464:
417:
392:
382:
374:
341:
281:
256:
246:
768:30817
535:S2CID
478:S2CID
72:is a
727:PMID
719:ISSN
680:PMID
672:ISSN
631:PMID
623:ISSN
582:PMID
574:ISSN
527:PMID
519:ISSN
470:PMID
462:ISSN
415:ISBN
390:PMID
372:ISSN
339:ISBN
279:ISBN
254:PMID
121:mood
711:doi
662:doi
613:doi
566:doi
509:doi
505:157
454:doi
380:PMC
335:343
244:PMC
234:doi
172:HDL
144:BMI
92:or
810::
790::
766::
725:.
717:.
707:28
705:.
701:.
678:.
670:.
658:46
656:.
652:.
629:.
621:.
609:54
607:.
603:.
580:.
572:.
562:57
560:.
556:.
533:.
525:.
517:.
503:.
499:.
476:.
468:.
460:.
450:34
448:.
444:.
388:.
378:.
366:.
362:.
337:.
252:.
242:.
228:.
224:.
146:.
104:.
68:A
755:D
733:.
713::
686:.
664::
637:.
615::
588:.
568::
541:.
511::
484:.
456::
429:.
396:.
368:9
347:.
314:.
293:.
260:.
236::
230:7
209:.
31:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
